Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

  |  Issue: November 2016  |  

Kimberly J. Retzlaff is a freelance medical journalist based in Denver.

References

  1. Desai RJ, Huybrechts KF, Bateman BT, et al. Patterns and secular trends in use of immunomodulatory agents during pregnancy in women with rheumatic conditions. Arthritis Rheumatol. 2016 May;68(5):1183–1189.
  2. Hoes JN, Jacobs JW, Boers M, et al. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2007 Dec;66(12):1560–1567.
  3. Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol. 2006 Aug;20(4):685–694.
  4. de Man YA, Dolhain RJ, van de Geijn FE, et al. Disease activity of rheumatoid arthritis during pregnancy: Results from a nationwide prospective study. Arthritis Rheum. 2008 Sep;59(9):1241–1248.
  5. Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum. 1999 Jun;42(6):1219–1227.
  6. Ostensen M. The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol. 1992 Oct–Dec;28(3–4):235–237.
  7. Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am. 2007 May;33(2):237–252, v.
  8. Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010 Nov;5(11):2060–2068.
  9. Clowse ME, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006 Nov;54(11):3640–3647.
  10. Kim SC, Yelin E, Tonner C, Solomon DH. Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983–2009. Arthritis Care Res (Hoboken). 2013 Sep;65(9):1529–1533.
  11. Nielsen OH, Loftus EV Jr., Jess T. Safety of TNF-α inhibitors during IBD pregnancy: A systematic review. BMC Med. 2013 Jul 31;11:174.
  12. Panchal S, Khare M, Moorthy A, Samanta A. Catch me if you can: A national survey of rheumatologists and obstetricians on the use of DMARDs during pregnancy. Rheumatol Int. 2013 Feb;33(2):347–353.

Related Articles

    Why & How to Pursue Shared Decision Making with Your Patients

    Over the past several decades, the medical community has been moving toward a model of shared decision making. In addition to its ethical advantages, shared decision making potentially yields such benefits as improved medical adherence and better health outcomes. With the proliferation of treatment options and changes in the larger culture, shared decision making is…

    AndreyCherkasov / Shutterstock.com

    Rheumatic Disease Does Not Preclude Pregnancy

    Preconception planning is essential to help women with autoimmune disease have optimal pregnancy outcomes. Unplanned pregnancy can also negatively impact disease course in some patients. Yet many rheumatologic patients of childbearing age do not receive adequate contraception or prepregnancy education and counseling. Rheumatologists must work collaboratively with other healthcare providers to make sure rheumatic patients…